Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04296331 · ClinicalTrials.gov registry record
HIV Jail POC-AgAB Testings
A clinical trial of HIV/AIDS, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 6,613
- Enrollment target
- 1
- Study location
NCT04296331: Completed study of HIV/AIDS, sponsored by Montefiore Medical Center.
NCT04296331 is a study of HIV/AIDS that has completed, run by Montefiore Medical Center. The registered enrollment target is 6,613 participants, below the 33,072-participant average among 61 other HIV/AIDS trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04296331, a study of HIV/AIDS, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 6,613 participants
- Enrollment target
- 1
- Study location
Study Summary
"Enhancing a universal testing and treatment strategy in jail to promote viral load suppression among justice-involved people living with HIV" is an observational research study led by Dr. Matthew Akiyama, MSc of Albert Einstein College of Medicine and Montefiore Medical Center and Dr. Anne Spaulding, MPH of Emory University's Rollins School of Public Health. Due to the high rates of undiagnosed Human Immunodeficiency Virus (HIV) in the correctional setting and the short length of stay in jails, this study aims to evaluate whether care coordination within the D.C. Central Detention Facility (DC DOC) and upon release, including testing procedures and antiretroviral therapy (ART) initiation, can improve the connection of adults (age 18 and over) living with HIV to care in the community. The researchers will retrospectively look at the aggregate-level de-identified data of roughly 3,000 individuals admitted to the DC DOC over a 6-month period to determine the most effective HIV diagnostic test for routine opt-out testing in the correctional setting. Over the course of these 6 months, the correctional facility will transition from using POC only to POC + antigen/antibody (Ag/Ab), to solely using Ag/Ab, each for a 2-month duration. Individuals from this time period who are identified by corrections staff as HIV-positive either through testing upon admission, their electronic medical record (EMR) or self-report, and have a known release date will be considered eligible for the follow-up study to assess if care coordination is effective in linking others with HIV leaving the DC DOC to care. This follow-up will enroll 100 of these individuals who have consented to participate following their release from the DC DOC, and will consist of a chart review of their DC DOC EMRs and those from their community healthcare provider for up to two years after their release.
Primary Outcome
To determine the most effective HIV diagnostic test for routine opt-out testing in the correctional setting
Conditions Studied
Interventions
- DIAGNOSTIC_TEST POC
- DIAGNOSTIC_TEST Ag/Ab
- DIAGNOSTIC_TEST POC + Ag/Ab
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,613 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2023-04-30 |
What the finished NCT04296331 record still lists
NCT04296331 is an observational study that tracks outcomes without assigning an intervention. Its 6,613 participants enrollment target places it among the larger protocols in the corpus, below the 33,072-participant average among 61 other HIV/AIDS trials with a reported enrollment target (80% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 3 interventions - of which POC is the first listed.
NCT04296331 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04296331 about?
NCT04296331 is a clinical study titled "HIV Jail POC-AgAB Testings". "Enhancing a universal testing and treatment strategy in jail to promote viral load suppression among justice-involved people living with HIV" is an observational research study led by Dr. Matthew Akiyama, MSc of Albert Einstein College of Medicine and Montefiore Medical Center and Dr. Anne Spauldin...
What is the current status of trial NCT04296331?
This trial is currently completed. The enrollment target is 6,613 participants. The study started on 2019-10-14. Estimated completion is 2023-04-30.
What conditions does trial NCT04296331 study?
This clinical trial studies the following conditions: HIV/AIDS.
What interventions are being tested in trial NCT04296331?
The interventions under investigation include: POC (DIAGNOSTIC_TEST), Ag/Ab (DIAGNOSTIC_TEST), POC + Ag/Ab (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04296331?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04296331 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04296331's enrollment target sits among peer trials
6,613 2nd of 61 the highest of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
- NCT05515224 · 6,600 participants · NA
5-Cog 2.0: A Pragmatic Clinical Trial
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI